[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100608442":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":15,"locations":10,"responsibleParty":21,"collaborators":23,"id":27,"slug":28,"hasResults":29,"nctId":30,"briefTitle":31,"officialTitle":32,"acronym":10,"eligibilityCriteria":33,"healthyVolunteers":34,"sex":35,"minAge":36,"maxAge":37,"enrollmentInfo":38,"targetDuration":10,"studyType":41,"phases":10,"briefSummary":42,"conditions":43,"keywords":45,"overallStatus":59,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":10},{"fullName":5,"class":6},"Blekinge Institute of Technology","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Parkinson disease",null,"Inclusion criteria for Parkinson's group:\n\n* Age 60-80 years\n* Diagnosis of idiopathic Parkinson's disease\n* Ability to understand spoken and written Swedish\n* Ability to personally provide consent to participate in the study\n* At least one healthy eye for retinal photography",{"label":13,"type":10,"description":14,"interventionNames":10},"Healthy controls","Inclusion criteria for control group:\n\n* Age 60-80 years\n* Ability to understand spoken and written Swedish\n* Ability to personally provide consent to participate in the study\n* At least one healthy eye for retinal photography\n\nDefinition of healthy:\n\n* No diagnosed Parkinson's disease or currently under investigation for Parkinson's disease\n* No diagnosed cognitive disease or currently under investigation for cognitive disease\n* No psychiatric disease affecting cognition (e.g., psychotic disorder or major depression)\n* Cognitive testing score of MMSE ≥ 26 points (out of a maximum of 30) and ≥ 8 points on the clock-drawing test",[16],{"name":17,"role":18,"phone":19,"phoneExt":10,"email":20},"Anders Behrens, MD. PhD.","CONTACT","0046455731000","anders.behrens@bth.se",{"type":22,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[24],{"name":25,"class":26},"Region Blekinge","UNKNOWN","100608442","non-invasive-diagnosis-of-parkinsons-disease-100608442",false,"NCT07201610","Non-invasive Diagnosis of Parkinson's Disease","Non-invasive Diagnosis of Parkinson's Disease Using Hyperspectral Retinal Imaging, Optical Coherence Tomography, Computerized Cognitive Testing, and Voice Analysis","Inclusion criteria for Parkinson's group:\n\n* Age 60-80 years\n* Diagnosis of idiopathic Parkinson's disease\n* Ability to understand spoken and written Swedish\n* Ability to personally provide consent to participate in the study\n* At least one healthy eye for retinal photography\n\nInclusion criteria for control group:\n\n* Age 60-80 years\n* Ability to understand spoken and written Swedish\n* Ability to personally provide consent to participate in the study\n* At least one healthy eye for retinal photography\n* Healthy as defined below\n\nExclusion criteria:\n\n* At least one eye must not have retinal disease, glaucoma, or vascular eye disease (such as embolism)\n* Angle-closure glaucoma or other contraindication to mydriatic drops\n* Low functional ability that makes participation in examinations impossible\n* Diagnosed dementia\n* Specifically for the control group: Not healthy according to the definition below\n\nDefinition of healthy:\n\n* No diagnosed or suspected Parkinson's disease\n* No diagnosed or suspected cognitive disease\n* No psychiatric disease affecting cognition (e.g., psychotic disorder or major depression)\n* Cognitive testing with MMSE ≥ 26 points (out of a maximum of 30) and ≥ 8 points on the clock-drawing test",true,"ALL","60 Years","80 Years",{"count":39,"type":40},60,"ESTIMATED","OBSERVATIONAL","This study will investigate new, non-invasive methods to help diagnose Parkinson's disease. Researchers will use advanced eye imaging (hyperspectral retinal photography and OCT), computerized memory and thinking tests, and voice analysis to identify patterns linked to Parkinson's. The goal is to improve early and accurate diagnosis of Parkinson's disease without the need for spinal taps or invasive tests.",[44],"Parkinsons Disease (PD)",[46,47,48,49,50,51,52,53,54,55,56,57,58],"Parkinson's disease","Non-invasive diagnosis","Hyperspectral retinal imaging","Optical coherence tomography","OCT","Computerized cognitive testing","Voice analysis","Biomarkers","Lewy body disease","Retinal biomarkers","Diagnostic accuracy","Neuropsychology","Machine learning","NOT_YET_RECRUITING","2025-09-30",{"date":62,"type":63},"2025-10-01","ACTUAL",{"date":65,"type":40},"2025-10-16",{"date":67,"type":40},"2025-12-16",{"name":5,"class":6}]